Insulin potential in preventing brain damage after traumatic brain injury: What we know
Bardia Hajikarimloo,Sama Jabbaripour,Amir Mohammad Tohidinia,Aysan Valinejad Qanati,Farzan Fahim,Pegah Javadpour,Rasoul Ghasemi
DOI: https://doi.org/10.1111/jne.13458
2024-11-13
Journal of Neuroendocrinology
Abstract:Traumatic brain injury (TBI) causes brain damage and affects insulin signaling and glucose utilization. Insulin resistance worsens brain function and increases the risk of neurodegeneration and impairment after TBI. Insulin therapy may help in the treatment of TBI by restoring glucose balance and improving brain function. Traumatic brain injury (TBI) is a major global cause of disability and mortality. TBI results in a spectrum of primary and secondary injuries that impact neural function and overall survival. Insulin, beyond its well‐known role in regulating blood glucose levels, plays critical roles in the central nervous system (CNS). These roles include the modulation of synaptic plasticity, neurotransmitter levels, neurogenesis, and neuroprotection. Central insulin resistance, a reduced sensitivity to insulin in the brain, has been observed in TBI patients. This insulin resistance impairs insulin function in the brain and increases the risk of neurodegenerative processes. This review will delve into the central role of insulin resistance in the pathological changes observed after TBI and explore the potential benefits of insulin therapy as a treatment approach for TBI.
neurosciences,endocrinology & metabolism
What problem does this paper attempt to address?